Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Corporate & Special Sales
    • Journal Claims
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Permissions
    • Advertisers
    • Continuing Education
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Follow JNM on Twitter
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Subscribe to our RSS feeds

More articles from MTA I: Prostate/GU Posters

  • You have access
    Prospective comparison of FCH PET/CT, contrast-enhanced CT and MRI for the characterisation and initial staging of prostate cancer
    Jean-Noel Talbot, Sona Balogova, Virginie Huchet, Khaldoun Kerrou, Valérie Nataf, Christophe Egrot, Clarisse Lafont and Marc Tassart
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1416;
  • You have access
    18F Choline PET/CT for assessing disease recurrence: Correlation with TRUS, MR template-guided prostate mapping biopsies
    Athar Haroon, Ahmad Almuhaideb, John Dickson, Mark Emberton, Irfan Kayani, Hashim Ahmed, Alex Freeman, Alex Kirkham, Jamshed Bomanji and Ashley Groves
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1415;
  • You have access
    F18-FDG-PET/CT in staging of carcinoma penis
    Jk Kirankumar, Senthil Raja, Manohar Kuruva, Raghava Kashyap, Anish Bhattacharya, Uttam Mete and Bhagwant Mittal
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1411;
  • You have access
    Prospective comparison of FCH PET/CT, contrast-enhanced CT and MRI in recurrent prostate cancer
    Virginie Huchet, Khaldoun Kerrou, Fabrice Gutman, Sona Balogova, Christophe Egrot, Valérie Nataf, Marc Tassart, Clarisse Lafont and Jean-Noel Talbot
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1420;
  • You have access
    F18-Sodium fluoride PET/CT for metastatic burden quantification in prostate cancer
    Esther Mena, Liza Lindenberg, Andrea Apolo, Yolanda McKinney, William Dahut, Peter Choyke and Karen Kurdziel
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1417;
  • You have access
    NaF18 PET/CT bone scans: Examining the value PSA=10ng/ml as a cutoff for predicting metastatic bone disease
    Aung Win and Carina Mari Aparici
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1404;
  • You have access
    11C-Choline PET/CT in hormonal resistant patients after radical prostatectomy
    Francesco Ceci, Paolo Castellucci, Riccardo Schiavina, Chiara Fuccio, Stefano Boschi, Daniele Romagnoli, Elena Tabacchi, Marcelo Mamede, Cristina Nanni and Stefano Fanti
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1407;
  • You have access
    Incidentalomas in FCH-PET/CT
    Laurence Champion, Anne Laure Giraudet, Veronique Edeline and Jean-Louis Alberini
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1421;
  • You have access
    CT and 18F-FDG PET/CT in staging or restaging of renal cell carcinoma
    Elgin Ozkan, Mine Araz, Cigdem Soydal, Mustafa Filik and Gulseren Aras
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1413;
  • You have access
    The clinical value of 18F-FDG PET/CT in the diagnosis and management of renal tumor
    Jian hua Zhang, Rong Fu Wang, Yan Fan, Xu he Liao, Xu chu Zhang and Zhan li Fu
    Journal of Nuclear Medicine May 1, 2012, 53 (supplement 1) 1405;

Pages

  • Previous
  • Next
  • 1
  • …
  • 6
  • 7
  • 8
  • 9
  • 10
  • 11
  • 12
  • 13
  • 14
SNMMI

© 2022 Journal of Nuclear Medicine

Powered by HighWire